RERE RERE
Company Profile ↓Company Overview
RERE (RERE) is a publicly traded company listed on with a market capitalization of $716.40M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 28.7% CAGR over the past five years.
Trades at an undemanding P/E of 3.2.
Carries low leverage with a debt-to-equity ratio of 0.11.
Recent Developments
- Dec 2025 Revenue of $21.05B (+28.9% YoY); net profit $336.29M.
- Trailing 12 Months Year-on-year growth — revenue +28.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 28.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 28.72% |
| 1 Year: | 28.91% |
Stock Price Performance
| 1 Year: | +31.98% |
| 6 Months: | -23.87% |
| 3 Months: | -1.13% |
| 1 Month: | +8.46% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)59.19 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 28.7% over 5 years.
CONS
- Trading 29.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 4.65B | 4.99B | 5.15B | 6.25B | 6.16B |
| Cost of Revenue | 3.62B | 3.96B | 4.09B | 5.03B | 4.82B |
| Gross Profit | 1.04B | 1.03B | 1.05B | 1.22B | 1.34B |
| Operating Expenses | 964.84M | 942.84M | 934.19M | 1.05B | 1.16B |
| Operating Income | 72.69M | 91.07M | 120.78M | 171.64M | 185.32M |
| EBITDA | 74.58M | 101.42M | 126.42M | 163.92M | 173.28M |
| Interest Expense | 1.89M | 1.74M | 1.26M | 1.15M | 2.12M |
| Pretax Income | 72.69M | 99.68M | 125.16M | 162.77M | 171.16M |
| Tax Provision | 6.27M | 17.31M | 16.88M | 16.28M | 19.02M |
| Net Income | 42.80M | 72.34M | 90.82M | 130.34M | 135.09M |
| Diluted EPS | 0.17 | 0.29 | 0.37 | 0.53 | 0.55 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 9.87B | 12.97B | 16.33B | 21.05B |
| Cost of Revenue | - | 7.60B | 10.34B | 13.09B | 16.70B |
| Gross Profit | - | 2.27B | 2.63B | 3.24B | 4.35B |
| Operating Expenses | - | 3.08B | 2.80B | 3.21B | 3.89B |
| Operating Income | - | -803.73M | -173.34M | 28.97M | 456.18M |
| EBITDA | - | -2.16B | 192.38M | 281.64M | 582.63M |
| Interest Expense | - | 6.16M | 7.06M | 15.02M | 6.04M |
| Pretax Income | - | -2.57B | -148.41M | -442.00K | 460.30M |
| Tax Provision | - | -111.78M | -42.53M | -56.88M | 56.75M |
| Net Income | - | -2.47B | -156.25M | -8.23M | 336.29M |
| Diluted EPS | - | -10.01 | -0.63 | -0.03 | 1.37 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 5.05B | 5.49B | 5.09B | 5.97B |
| Current Assets | - | 3.89B | 4.53B | 4.17B | 4.74B |
| Cash & Equivalents | - | 1.70B | 1.98B | 1.97B | 1.54B |
| Inventory | - | 433.47M | 1.02B | 535.07M | 1.07B |
| Receivables | - | 150.62M | 56.81M | 58.98M | 131.60M |
| Total Liabilities | - | 1.17B | 1.78B | 1.40B | 1.98B |
| Current Liabilities | - | 1.02B | 1.69B | 1.31B | 1.90B |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 203.93M | 405.94M | 354.93M | 456.61M |
| Total Equity | - | 3.88B | 3.71B | 3.69B | 3.99B |
| Shares Outstanding | - | 149.22M | 158.56M | 162.99M | 164.31M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 881.30M | 243.90M | 642.81M | -414.57M |
| Investing Cash Flow | - | -516.68M | 172.01M | -424.40M | -136.15M |
| Financing Cash Flow | - | -186.04M | 68.70M | -307.71M | -13.68M |
| Capital Expenditure | - | -61.46M | -85.18M | -59.86M | -144.28M |
| Free Cash Flow | - | 819.83M | 158.72M | 582.95M | -558.85M |
| Net Change in Cash | - | 178.57M | 484.61M | -89.30M | -564.40M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 23.0% | 20.3% | 19.9% | 20.7% |
| Operating Margin % | - | -8.1% | -1.3% | 0.2% | 2.2% |
| Net Margin % | - | -25.0% | -1.2% | -0.1% | 1.6% |
| ROE % | - | -63.6% | -4.2% | -0.2% | 8.4% |
| ROCE % | - | -20.0% | -4.6% | 0.8% | 11.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RERE
ATRenew's ReRe Store Brings Tested Pre-Owned Goods to Hong Kong - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNYnVkZFQwS3RwbjlIWW9TMG9OeElfUVdvSklxNmZRcFd6NUw0Wjc1aEFlRjA1bVNIcjE0cUVMSFBqaWVjTkJNNHY3bTFiSW05Zkl5VEVDb0pzYmtEUFROQ205UEtqa0YwNlhRa2VvVjJmVWx1dGNSM1BOejNUejNFUDRmTmZPMC03Um5zTU…
Best Rare Earth Stocks to Buy Now August 2026 - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE5Kb3JyUVVPQUU2Z1ZLN2xScXE0SldVZTNHSW5kYldwTmR2QnlEN3B1aTZkREE2VGNfMW9reDRUODNFY2ZkQU9lT1JHRTRTTWlTcmlFYkZ0RzhDQnRkeVk1RFBHYWdaRDZkeFZTNXZhWXFxdGhB?oc=5" target="_blank">Best Rare E…
Assessing ATRenew (NYSE:RERE) Valuation After Strong Q1 2026 Results And Optimistic Q2 Outlook - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOUTRPZHNiTHlTdE85ZlhieVJJTUwwc3JjUnZTelRQTHZFTzdRTXZDMk81TllUWmQ5S2FtUHdISXBUbDhSb29oMFgydFl0QkxacV92UmZUaEVrNjM5emRVdXQ0YXFLY3J5V2xnT05VQ1U3UC05N0ZEclNkQzRoRS1PR0pXTmZ0NExMVG9xaz…
RERE Initiated Coverage by UBS -- Rating Set to Buy with PT of $5.50 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNbzJzNEFTN3FBb1VHWlFETU91SDR6emtXLTlaeGw3VFZ6U0J0VHUxMFlWdk9PQ1NZb1N2WW1VVWVJZ3lLczR1bDAybkUyUGJTQTJnVW9abTlSZVZQSWl6ZnFSaFBGd2E3b1pCSjd4NDQ5MlQ1Q1pjM0FrZkpHaWZzcG5sWkFHc1ZkWG11TG…
ATRenew Inc. (NYSE:RERE) Surges After Q1 Earnings Beat Analysts’ Estimates - ChartMill
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPM3M3Q29yaGwwTzd5TmJtS1licTNWZlRDTkFuVEhxS3d4TXJhUUhNQlZnaWt5cURLUkx0OGIzLUR1MDhUck1VREx6Wm4yd0FEX1g1bGdrX1l3UUpiV3RWYzUyOWlkSHFXNm5jZVRCbVR2VHlqRU1GR0x5Mkh1cW94M0RHZXROVVVIVlh2Q0…
How Profit Uptick And Buybacks At ATRenew (RERE) Have Changed Its Investment Story - simplywall.st
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOUTJVamFRZGxqblJEQmp6T2d2OE01NUJORU9Wa3lvWVpEai1DOWFINXktN1FpSlRGMWNIUWpIbm9pTVdkYlpuN0tPdFh3SThaZUdvaFlsVGFHdFB3S3ZFQ1RkclZjMVVYanZhajUxSEE0dDMtaW5pMGVzdnJOcnBzTkhfeHYxcjJDSHNxa0…
RERE — Frequently Asked Questions
What is the current share price of RERE?
As of 2026-08-05 17:25 PDT, RERE trades at $4.36 on NASDAQ/NYSE. Its 52-week range is $3.30 to $6.20.
What is the market capitalisation of RERE?
RERE has a market capitalisation of $716.40M on NASDAQ/NYSE.
What is the P/E ratio of RERE?
RERE trades at a trailing price-to-earnings (P/E) ratio of 3.19. Its price-to-book (P/B) ratio is 0.18.
What is the return on equity (ROE) of RERE?
RERE has a return on equity (ROE) of 8.43%. Its return on capital employed (ROCE) is 11.23%.
Is RERE a good stock to buy?
This page provides a data-driven analysis of RERE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.